Amlin Plc
BOARD AND COMMITTEE CHANGES
As previously announced, Mr John Kennedy, Mr John Sanders and Mr John Stace did
not seek re-election as Directors at the Company's Annual General Meeting today,
and accordingly ceased to be non-executive Directors of Amlin at the conclusion
of that meeting.
It was announced at the AGM that Mr Ramanam Mylvaganam, who has been an
independent non-executive Director of the Company since 1998, has been appointed
by the Board to succeed Mr Kennedy as chairman of the Remuneration Committee. Mr
Nigel Buchanan, an independent non-executive Director appointed to the Board in
March 2004 and elected by shareholders at the AGM today, has also been appointed
to the Remuneration Committee. Lord Stewartby, the independent non-executive
Deputy Chairman, is the third member of that committee.
Following the AGM the members of the other Board Committees are:
Audit Committee: Lord Stewartby (chairman), Mr Nigel Buchanan, Mr Roger Joslin,
Mr Ramanam Mylvaganam; and
Nomination Committee: Mr Roger Taylor (chairman), Mr Roger Joslin, Mr Ramanam
Mylvaganam, Mr Charles Philipps, Lord Stewartby.
19 May 2004
Enquiries:
Charles Pender 020 7746 1000
Secretary
Amlin plc
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.